Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer. Cancer Res. 2020 02 01; 80(3):394-405.
View in:
PubMed
subject areas
Antineoplastic Agents, Alkylating
Cell Proliferation
DNA Replication
DNA, Neoplasm
Female
Gain of Function Mutation
Humans
Minichromosome Maintenance Complex Component 2
Poly (ADP-Ribose) Polymerase-1
Triple Negative Breast Neoplasms
Tumor Suppressor Protein p53
authors with profiles
Olufunmilayo Olopade